Medical insurance nucleic acid testing reimbursement. At present, the cost of nucleic acid testing has been fully included in the medical insurance reimbursement, which means that the cost of nucleic acid monitoring during hospitalization can be fully reimbursed. If it is an outpatient clinic, the patient needs to use the medical insurance card at his own expense or part of his personal account. In the aspect of nucleic acid detection, if it is really necessary to set up temporary projects to meet the needs of COVID-19 detection fees of public medical institutions, all localities are encouraged to set up projects by means of "separation of technology and consumption". Consumables such as sample collection, processing, labeling, recovery, diagnosis results and nasopharyngeal swabs used for nucleic acid and antibody detection should be combined into medical service price items; In vitro diagnostic kits are charged at "zero difference rate" outside the medical service price items.

People's Republic of China (PRC) social insurance law

Article 2 The state establishes social insurance systems such as basic old-age insurance, basic medical insurance, industrial injury insurance, unemployment insurance and maternity insurance, so as to guarantee citizens' right to receive material assistance from the state and society in accordance with the law in case of old age, illness, industrial injury, unemployment and maternity.

Article 3 The social insurance system adheres to the principles of wide coverage, basic protection, multi-level and sustainability, and the level of social insurance should be compatible with the level of economic and social development.

Twenty-eighth medical expenses that meet the basic medical insurance drug list, diagnosis and treatment items, medical service facilities standards and emergency treatment and rescue shall be paid by the basic medical insurance fund in accordance with state regulations.